$3.890
-0.226 (-5.81%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ORMP por análisis de gráficos similares
Alphio's ORMP stock price prediction model matches the current Oramed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.90 (+0.38%). The 1-week path is $3.90 (+0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Oramed Pharmaceuticals Inc?
Oramed Pharmaceuticals Inc is currently trading at $4, which is 56.5% of its 52-week range, indicating it is closer to its 52-week high of $5.47. However, the RSI is at a low 29.89, suggesting the stock is oversold. The company reported a profit of $10 million in Q4, translating to an EPS of $0.24, which reflects strong profitability despite low revenue. The main risk is the significant drop in revenue with total revenue reported as $2 million in Q1 2025 and a projected earnings surprise of -120.93% in the last earnings report, indicating potential volatility ahead.
ORMP cerró en $3.89 el Thursday, tras bajar -5.81%
Oramed Pharmaceuticals Inc (ORMP) last closed at $3.8900001, losing -5.81%. These facts feed the 1-day and 1-week ORMP price prediction above.
Consenso de analistas
Oramed Pharmaceuticals Inc (ORMP): 2 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Oramed Pharmaceuticals Inc (ORMP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ORMP, ordenadas por similitud.
Análisis de estacionalidad de ORMP
Historically the probability of a positive November return for ORMP is 32.56%. December offers the highest probability of a positive month at 74.42%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ORMP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.92 | $2.16 | $2.28 | -44.39% |
| Dec 2026 | $2.47 | $2.51 | $2.54 | -35.53% |
En 2026, se proyecta que Oramed Pharmaceuticals Inc (ORMP) oscile entre $1.92 y $2.54.
Previsión mensual de Oramed Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Oramed Pharmaceuticals Inc promedie $2.16, con un mínimo de $1.92 y un máximo de $2.28.
En Dec de 2026, se proyecta que Oramed Pharmaceuticals Inc promedie $2.51, con un mínimo de $2.47 y un máximo de $2.54.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.